UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells

Cell death and differentiation, 2007-09, Vol.14 (9), p.1678-1687

2007

Volltextzugriff (PDF)

Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas

Gut, 2006-02, Vol.55 (2), p.234-242

2006

Volltextzugriff (PDF)

Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosity

Neuropathology and applied neurobiology, 2014-02, Vol.40 (2), p.205-216

2014

Volltextzugriff (PDF)

Apoptosis regulators and their role in tumorigenesis

BBA - Reviews on Cancer, 2001-10, Vol.1551 (2), p.F1-F37

2001

Volltextzugriff (PDF)

Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms

Oncogene, 2013-05, Vol.32 (20), p.2586-2591

2013

Volltextzugriff (PDF)

A pro-apoptotic function of iASPP by stabilizing p300 and CBP through inhibition of BRMS1 E3 ubiquitin ligase activity

Cell death & disease, 2015-02, Vol.6 (2), p.e1634-e1634

2015

Volltextzugriff (PDF)

Inhibition of the oncoprotein FUBP1 by SN-38 represents a novel therapeutic option for the treatment of hepatocellular carcinoma

European journal of cancer (1990), 2016-12, Vol.69, p.S18-S18

2016

Volltextzugriff (PDF)

Valproic acid induces extracellular signal-regulated kinase 1 2 activation and inhibits apoptosis in endothelial cells

Cell death and differentiation, 2006-03, Vol.13 (3), p.446-453

2006

Volltextzugriff (PDF)

The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potential

Cell death and differentiation, 2012-09, Vol.19 (9), p.1435-1445

2012

Volltextzugriff (PDF)

Agonists of an ecdysone-inducible mammalian expression system inhibit Fas Ligand- and TRAIL-induced apoptosis in the human colon carcinoma cell line RKO

Cell death and differentiation, 2006-02, Vol.13 (2), p.189-201

2006

Volltextzugriff (PDF)

128: Loss of far upstream element (FUSE) binding protein (FBP)- interacting repressor (FIR) function supports HCC growth

European journal of cancer (1990), 2014-07, Vol.50, p.S28-S28

2014

Volltextzugriff (PDF)

Requirement for the CD95 Receptor-Ligand Pathway in c-Myc-Induced Apoptosis

Science (American Association for the Advancement of Science), 1997-11, Vol.278 (5341), p.1305-1309

1997

Volltextzugriff (PDF)

1092 Assessing the Potential of Novel Antigens as Targets for Immunotherapeutic Approaches in Pancreatic Carcinoma

European journal of cancer (1990), 2012-07, Vol.48, p.S263-S263

2012

Volltextzugriff (PDF)

Palmitoylation of human FasL modulates its cell death-inducing function

Cell death & disease, 2010-10, Vol.1 (10), p.e88-e88

2010

Volltextzugriff (PDF)

Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells

Cell death and differentiation, 2006-03, Vol.13 (3), p.446

2006

Volltextzugriff (PDF)

Human Bak induces cell death in Schizosaccharomyces pombe with morphological changes similar to those with apoptosis in mammalian cells

Molecular and Cellular Biology, 1997-05, Vol.17 (5), p.2468-2474

1997

Volltextzugriff (PDF)

p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice

Current biology, 1998-04, Vol.8 (8), p.467-470

1998

Volltextzugriff (PDF)

A Dominant Negative Fas-associated Death Domain Protein Mutant Inhibits Proliferation and Leads to Impaired Calcium Mobilization in Both T-cells and Fibroblasts

The Journal of biological chemistry, 2000-04, Vol.275 (14), p.10453-10462

2000

Volltextzugriff (PDF)

Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2

Oncogene, 1996-04, Vol.12 (8), p.1789-1801

1996

Volltextzugriff (PDF)

Fas ligand is localized to membrane rafts, where it displays increased cell death–inducing activity

Blood, 2006-03, Vol.107 (6), p.2384-2391

2006

Volltextzugriff (PDF)

Cell cycle: On target with Myc

Current biology, 1996-12, Vol.6 (12), p.1553-1556

1996

Volltextzugriff (PDF)

Steigerung der Apoptoserate durch kombinierte PI3K/mTOR- und Proteasom-Inhibition bei kolorektalen Karzinomzelllinien

Zeitschrift für Gastroenterologie, 2011, Vol.49 (8)

2011

Volltextzugriff (PDF)

The role of Bcl-2 family members in tumorigenesis

BBA - Molecular Cell Research, 2004-03, Vol.1644 (2), p.229-249

2004

Volltextzugriff (PDF)

FUBP1 (far upstream element (FUSE) binding protein 1)

Atlas of genetics and cytogenetics in oncology and haematology, 2013-11 (12)

2013

Volltextzugriff (PDF)

Reduziertes Wachstum kolorektaler Karzinomzelllinien-Xenografts nach kombinierter EGF-Rezeptor- und PI3K/AKT/mTOR-Inhibition

Zeitschrift für Gastroenterologie, 2010, Vol.48 (8)

2010

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(113)

Publikationsform

Artikel
(147)
Tagungsberichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells

Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas

Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosity

Apoptosis regulators and their role in tumorigenesis

Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms

A pro-apoptotic function of iASPP by stabilizing p300 and CBP through inhibition of BRMS1 E3 ubiquitin ligase activity

Inhibition of the oncoprotein FUBP1 by SN-38 represents a novel therapeutic option for the treatment of hepatocellular carcinoma

Valproic acid induces extracellular signal-regulated kinase 1 2 activation and inhibits apoptosis in endothelial cells

The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potential

Agonists of an ecdysone-inducible mammalian expression system inhibit Fas Ligand- and TRAIL-induced apoptosis in the human colon carcinoma cell line RKO

128: Loss of far upstream element (FUSE) binding protein (FBP)- interacting repressor (FIR) function supports HCC growth

Requirement for the CD95 Receptor-Ligand Pathway in c-Myc-Induced Apoptosis

1092 Assessing the Potential of Novel Antigens as Targets for Immunotherapeutic Approaches in Pancreatic Carcinoma

Palmitoylation of human FasL modulates its cell death-inducing function

Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells

Human Bak induces cell death in Schizosaccharomyces pombe with morphological changes similar to those with apoptosis in mammalian cells

p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice

A Dominant Negative Fas-associated Death Domain Protein Mutant Inhibits Proliferation and Leads to Impaired Calcium Mobilization in Both T-cells and Fibroblasts

Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2

Fas ligand is localized to membrane rafts, where it displays increased cell death–inducing activity

Cell cycle: On target with Myc

Steigerung der Apoptoserate durch kombinierte PI3K/mTOR- und Proteasom-Inhibition bei kolorektalen Karzinomzelllinien

The role of Bcl-2 family members in tumorigenesis

FUBP1 (far upstream element (FUSE) binding protein 1)

Reduziertes Wachstum kolorektaler Karzinomzelllinien-Xenografts nach kombinierter EGF-Rezeptor- und PI3K/AKT/mTOR-Inhibition

Suchergebnisse filtern